Cargando…
Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer
BACKGROUND: Aberrant patterns of microRNA expression have been highlighted as a potential clinical biomarker in breast cancer as the most frequent cancer among women that contributes nearly a quarter of total cancer incidence in 2018. Upregulation of microRNA-21 (miR-21) is associated with adverse c...
Autores principales: | Anwar, Sumadi Lukman, Sari, Dwi Nur Indah, Kartika, Aprilia Indra, Fitria, Meutia Srikandi, Tanjung, Dewi Sahfitri, Rakhmina, Dinna, Wardana, Tirta, Astuti, Indwiani, Haryana, Sofia Mubarika, Aryandono, Teguh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948877/ https://www.ncbi.nlm.nih.gov/pubmed/31030498 http://dx.doi.org/10.31557/APJCP.2019.20.4.1223 |
Ejemplares similares
-
Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer
por: Anwar, Sumadi Lukman, et al.
Publicado: (2020) -
Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma
por: Wardana, Tirta, et al.
Publicado: (2022) -
Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma
por: Wardana, Tirta, et al.
Publicado: (2020) -
MicroRNA-155-5p Diminishes in Vitro Ovarian Cancer Cell Viability by Targeting HIF1α Expression
por: Ysrafil, Ysrafil, et al.
Publicado: (2020) -
Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer
por: Fitriawan, Akbar Satria, et al.
Publicado: (2020)